Creative Biolabs has a tradition of commitment. To achieve efficient execution and regulatory approval, we offer careful considerations of your program for the development of a cellular or gene therapy product – now and in the future.
EXPLORE MORE HighlightsWe focus on unmet needs and develop novel cellular and gene drugs and solutions that offer significant benefits over existing options.
EXPLORE MORE HighlightsThe advent of Chimeric Antigen Receptor T-cell (CAR-T) therapies has revolutionized the field of oncology, providing new avenues for treating various forms of cancer. Our 20 years of experience in the biotechnology sector have equipped us with the expertise and technological capabilities to support the entire lifecycle of CAR-T products, from early development to commercialization.
EXPLORE MORETo accelerate advanced breakthroughs of your projects, we offer broad range of platforms which enable our clients be free to tackle problems with cutting-edge technologies from different angles and in different methods.
EXPLORE MORE HighlightsUse the resources in our library to help you understand your options and make critical decisions for your study. We offer oncolytic virus, CAR-T, and dendritic cell related documents, as well as newsletter. If you don't find the answers you're looking for, contact us for additional assistance.
EXPLORE MORE HighlightsGet a real taste and understanding of the business and culture of one of the world's great research-based cellular and gene therapy discovery and development companies.
EXPLORE MORENeutralizing antibody (NAb) is responsible for blocking the entry of a pathogen into a cell. Creative Biolabs provides human leukocyte antigen (HLA) neutralizing assay to assess the neutralizing activity of HLA antibodies against virus-carrying HLA alleles.
NAb is an antibody that is responsible for defending cells from pathogens. As part of the immune response, pathogens are triggered by both infections and vaccinations against infections. Neutralizing antibodies can result in lifelong immunity to certain infections and can be used to see if a person has developed immunity to an infection after they have recovered from it.
At present, many antibody therapies based on neutralization mechanisms have emerged for the treatment of various diseases including but not limited to infectious diseases and endocrine disorders. The neutralizing assays are specially designed to routinely validate and measure the therapeutic action of such antibodies. The role of neutralizing antibodies is as follows:
Creative Biolabs offers HLA antibody neutralizing assays that are specifically designed to measure antibody neutralization potential against different targets, including but not limited to virus, cytokine, and toxin.
Fig.1 Workflow of HLA neutralizing assay.
Except for HLA neutralizing assay, Creative Biolabs offers a complete range portfolio of HLA testing assays. For more information, please feel free to contact us directly.
For any technical issues or product/service related questions, please leave your information below. Our team will contact you soon.
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
NEWSLETTER
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTER
NEW SOLUTION
CellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTION
NOVEL TECHNOLOGY
Silence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGY
NEW SOLUTION
Canine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION
